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A personal experience with coronary artery bypass
grafting, carotid patching, and other factors
influencing the outcome of carotid
endarterectomy
Norman R. Hertzer, MD,a and Edward J. Mascha, PhD,b Cleveland, Ohio
Objective: This study was conducted to investigate the influence of coronary artery bypass grafting (CABG), carotid
patching, and other factors on the outcome of all carotid endarterectomies (CEAs) performed by a single surgeon at a
tertiary referral center.
Methods: The series includes 2262 CEAs (335 bilateral) in 1521 men and 741 women (33%) with median ages of 66 and
68 years, respectively. Surgical indications were asymptomatic stenosis for 1503 procedures (66%), retinal ischemia or
cerebral transient ischemic attacks each for 271 (12%), and prior stroke for 217 (9.6%). CEA was done as an isolated
operation in 1959 patients and was performed in conjunction with simultaneous CABG in 303 (13%). Primary
arteriotomy closure was used for 783 CEAs (35%), vein patching for 1232 (54%), and synthetic patching for 247 (11%).
Outcome event rates were assessed by logistic regression analysis, proportional hazards models, and Kaplan-Meier
estimations.
Results: Postoperative mortality (odds ratio [OR], 3.5; 95% confidence interval [CI], 1.7 to 7.5; P  .001), stroke (OR,
3.2; 95% CI, 1.6 to 6.4; P .001), and combined stroke and mortality rates (OR, 3.4; 95% CI, 2.0 to 5.8; P< .001) were
significantly higher for simultaneous CEA/CABG than for isolated CEA. Ipsilateral postoperative stroke rates were
similar (2.6% vs 1.7%, P  .41) in both settings. Vein patching had a lower risk for ipsilateral stroke (OR, 0.42; 95% CI,
0.21 to 0.86; P  .015) than primary closure, but was not significantly different from synthetic patching (P  .10). The
documented incidence of postoperative carotid thrombosis was 1.5% with primary closure, 0.6% with vein patching, and
2.0%with synthetic patching (P .088). Overall Kaplan-Meier survival was 92% at 1 year, 71% at 5 years, 41% at 10 years,
and 20% at 15 years, but long-term mortality rates were higher after simultaneous CEA/CABG (hazard ratio, 1.3; 95%
CI, 1.1 to 1.5; P  .002) than after CEA alone. Late strokes or retinal infarctions have been reported after 97 (5.0%) of
the 1923 operations for which follow-up was available, 51 (2.3%) of which were ipsilateral to CEA. The incidence of
>60% recurrent stenosis was independently influenced by carotid patching (OR, 0.61; 95% CI, 0.40 to 0.92; P  .019)
but not by the choice of patch material (P  .11).
Conclusions: These results substantiate the common observation that patients who require simultaneous CEA/CABG
have a higher risk for adverse outcomes than patients who undergo isolated CEA. Carotid patching provided significant
benefit with respect to the risks for ipsilateral postoperative stroke and >60% recurrent stenosis. ( J Vasc Surg 2006;43:
959-68.)After decades of debate, several randomized controlled
trials now have demonstrated that carotid endarterectomy
(CEA) confers significant improvement in long-term stroke
protection compared with best medical management.
These conclusions are not applicable to other practice
settings, however, unless CEA can be shown to have com-
bined 30-day stroke and mortality rates that are equivalent
to those for the symptomatic patients in the North Ameri-
can Symptomatic Carotid Endarterectomy Trial (6.5%)1
and the European Carotid Surgery Trial (6.8%),2 as well as
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doi:10.1016/j.jvs.2005.12.060for the asymptomatic patients in the Asymptomatic Carotid
Atherosclerosis Study (1.5%)3 and the Asymptomatic Ca-
rotid Surgery Trial (3.1%).4 The present study investigated
factors influencing the safety and durability of CEA in the
personal experience of one of the authors (N.R.H.) during
28 years at The Cleveland Clinic, with particular attention
to coronary artery bypass grafting (CABG) and carotid
patching.
METHODS
The senior author performed 2343 CEAs from July
1976 through December 2002. Of these, 38 (1.6%) were
confined to the external carotid artery, and 43 (1.8%) were
done at the same time as aortic arch grafts, carotid-
subclavian or subclavian-carotid bypass, vertebral artery
reconstruction, or carotid replacement grafts. The remain-
ing 2262 operations (1927 patients) represented standard
bifurcation CEAs and serve as the basis for the present
report. During the study period, 335 patients (17%) under-
went bilateral CEAs, 222 (66%) of which were closely
959
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the severity of the initial imaging findings, or both. Of the
2262CEAs, 1959 were isolated procedures, and 303 (13%)
were performed in conjunction with simultaneous CABG.
Cardiac valve repair was also required in 17 (5.6%) of these
303 patients, and 14 (4.6%) had a history of previous
CABG.
Demographic information and perioperative complica-
tions were recorded contemporaneously on index cards or
in a computerized departmental registry throughout the
study period. The senior author supplemented this material
in 2004 by personally reviewing the electronic medical
record and 1914 (99%) of the 1927 conventional charts
containing all hospitalizations and outpatient visits. Addi-
tional information on patient survival was obtained from
the Social Security Death Index. The complete dataset then
was entered into Excel computer software (Microsoft Corp,
Redmond, Wash) for analysis. This investigation was ap-
proved by The Cleveland Clinic Institutional Review Board
and complies with the confidentiality requirements of the
Health Insurance Portability and Accountability Act of
1996.
Patient characteristics. Patients who underwent bi-
lateral CEAs often had unique clinical features (eg, age,
symptoms, and severity of carotid stenosis) at the time of
each of their two operations. Therefore, with the exception
of long-term survival, data are expressed on the basis of the
preoperative profile preceding all 2262 CEAs. In this con-
text, the series includes 1521 men (67%) and 741 women
with mean ages of 66.0 and 67.4 years (median, 66 and 68
years), respectively. Patient age rose incrementally
throughout the study period irrespective of the surgical
setting (Table I). Asymptomatic carotid stenosis was the
surgical indication for 1503 operations (66%) and was by
far the most common reason for CEA (242/303, 80%) in
the simultaneous CEA/CABG group (Table II). Of the
1503 CEAs that were classified as being done for asymp-
tomatic stenosis, 136 (9.0%) were associated with previous
nonspecific vertebrobasilar complaints. Ipsilateral cortical
transient ischemic attacks (TIAs) had occurred in 271
patients (12%), amaurosis fugax in 203 (9.0%), retinal
infarctions in 47 (2.1%), ischemic retinopathy in 8 (0.4%),
Table I. Age, gender and patch materials during five arbit
Isolated carotid endarterectomy
n
Median
age
Men Vein patch
N % n %
1976-1980 413 63 284 69 9 2.2
1981-1985 496 66 335 68 237 48
1986-1990 352 67 238 68 310 88
1991-1995 300 70 187 62 235 78
1996-2002 398 71 255 64 263 66
Total 1959 67 1299 66 1054 54and asymptomatic Hollenhorst plaques in 13 (0.6%). Anipsilateral stroke had occurred in 217 patients (9.6%). In
addition, 94 patients (4.2%) also had sustained previous
strokes involving the contralateral cerebral hemisphere.
Preoperative carotid arteriograms were obtained before
88% (1994/2262) of the CEAs and were done routinely
before simultaneous CEA/CABG (296/303, 98%). A du-
plex ultrasound scan was the only preoperative imaging
study in 268 patients (12%). One hundred and seventy
operations (7.5%) were performed for60% stenosis of the
internal carotid artery (ICA), 164 (96%) of which were
preceded by ipsilateral symptoms. Most procedures (n 
1764, 78%) were done for 80% to 99% stenosis, however,
and at least 90% stenosis was estimated to be present on
1145 (57%) of the 1994 preoperative arteriograms. (Arte-
riographic measurements were made using the North
American Symptomatic Carotid Endarterectomy Trial/
Asymptomatic Carotid Atherosclerosis Study criteria for
ICA stenosis during the last 15 years of the study period,
but previously represented visual estimates using the pro-
jected contour of the carotid bulb and for this reason
corresponded more closely to the European Carotid Sur-
gery Trial criteria2,3) A total of 1504 CEAs were performed
in the presence of60% stenosis of the contralateral carotid
artery, and 271 were done in patients who were known to
have had contralateral ICA (n  260) or common carotid
artery (CCA, n 11) occlusions. Fifty-five (59%) of the 94
patients with contralateral strokes had contralateral carotid
occlusions, whereas 55 (20%) of the 271 patients with
contralateral carotid occlusions had contralateral strokes.
In the isolated CEA group, 184 patients either received
or were scheduled to have CABG as a staged procedure
either before (n  93) or after (n  91) their CEAs were
done. Another 177 patients (7.8%) were under evaluation
for miscellaneous non-CABG procedures at the time their
incidental carotid disease was discovered, including 121
patients (5.3%) for whom noncarotid vascular procedures
were planned.
Surgical considerations. The technical aspects of
CEA in this series have been described in another report.5
With rare exceptions, nearly all operations were performed
by using general endotracheal anesthesia and intraoperative
carotid shunting. During the first 7 years of the study
time intervals.
Simultaneous coronary artery bypass grafting
thetic
atch
n
Median
age
Men Vein patch
Synthetic
patch
% n % n % n %
0.2 76 62 56 74 0 — 0 —
2.2 87 64 62 71 40 46 0 —
11 65 67 52 80 64 98 0 —
21 41 68 31 76 40 98 0 —
34 34 70 21 62 34 100 0 —
12 303 66 222 73 178 59 0 —rary
Syn
p
n
1
11
37
64
134period, patching was used only in selected patients who had
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The greater saphenous vein was the preferred patch mate-
rial and often was harvested from the ankle until about
1990, after which it was obtained strictly from the groin to
prevent central necrosis and patch rupture.6-8 No synthetic
patches were used for CEAs that were done in conjunction
with simultaneous CABG because of a potential risk for
patch contamination and because the saphenous vein usu-
ally was already exposed for CABG purposes. In aggregate,
primary arteriotomy closure was used for 783 (35%) of the
2262 CEAs in this series, vein patches for 1232 (54%),
fabric patches for 188 (8.3%), and polytetrafluoroethylene
(PTFE) patches for 59 (2.6%). A number of considerations,
including patient preference, contributed to the use of
synthetic patching, the most important being that 124
(50%) of the 247 synthetic patches were necessary in pa-
tients whose saphenous veins previously had been harvested
for CABG.
Follow-up protocol. Patients were encouraged to re-
turn for an annual objective assessment of their carotid
Table II. Selected clinical features
Isolated carotid
endarterectomy
n %
Operations 1959 87
Preoperative symptoms
Asymptomatic 1261 64
Retinal symptoms or signs 257 13
Amaurosis fugax 189 9.6
Retinal infarction 47 2.4
Ischemic retinopathy 8 0.4
Hollenhorst plaque 13 0.7
Transient cerebral ischemia 240 12
Prior stroke 201 10
Ipsilateral carotid stenosis
60% 159 8.1
60% to 79% 295 15
80% to 99% 1502 77
Common carotid occlusion 2 0.1
Internal carotid occlusion 1 0.05
Contralateral carotid stenosis
60% 1324 68
60% to 79% 188 9.6
80% to 99% 149 7.6
Common carotid occlusion 10 0.5
Internal carotid occlusion 224 11
Data not available 64 3.3
Previous CEA
Ipsilateral 74 3.8
Contralateral 410 21
Staged procedures
Contralateral CEA 187 9.5
Coronary artery bypass 184 9.4
CEA first 91 4.7
Coronary bypass first 93 4.6
Miscellaneous 165 8.4
Non-carotid vascular 109 5.6
CEA, Carotid endarterectomy.arteries for at least the first 3 postoperative years. Biannualfollow-up then was recommended in the absence of recur-
rent lesions on the operated side or contralateral disease
20% to 39% stenosis. Objective testing was done using
carotid compression tonography (CCT)9 during the
1970s, intravenous digital subtraction angiography during
the early 1980s, and duplex scanning since the mid-1980s.
Abnormal CCT tests routinely were investigated by arte-
riography. At least one objective study was performed after
1306 (59%) of the 2223 CEAs that were eligible for
follow-up in operative survivors. The median interval
(quartiles) between CEA and the most recent objective test
was 5.1 (2.3, 9.2) years for primary closure, 4.0 (2.0, 7.4)
years for vein patching, and 4.1 (1.7, 6.0) years for syn-
thetic patching.
Statistical analysis. The outcomes of primary interest
were postoperative death, postoperative stroke (any and
ipsilateral), combined postoperative stroke or mortality
(CSM), death at any time during follow-up, and the max-
imum severity of recurrent carotid stenosis. Associations
with these outcomes were assessed by using the baseline
Simultaneous
coronary artery bypass
grafting Total
n % n %
303 13 2262 100
242 80 1503 66
14 4.6 271 12
14 4.6 203 9
0 — 47 2.1
0 — 8 0.4
0 — 13 0.6
31 10 271 12
16 5.3 217 9.6
11 3.6 170 7.5
30 9.9 325 14
262 86 1764 78
0 — 2 0.09
0 — 1 0.04
180 59 1504 66
36 12 224 9.9
39 13 162 7.2
1 0.3 11 0.5
36 12 260 11
11 3.6 75 3.3
4 1.3 78 3.4
24 7.9 434 19
35 12 222 9.8
NA — NA —
NA — NA —
NA — NA —
12 4 177 7.8
12 4 121 5.3factors of gender; advancing categoric age (65, 66 to 74,
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tomatic, monocular visual, cortical TIA, or stroke in order
of increasing severity), preoperative ipsilateral and con-
tralateral carotid stenosis (60%, 60% to 79%, 80% to 99%,
or occlusion in order of increasing severity), staged CEA
and CABG (none, CEA first, or CABG first), isolated CEA
vs simultaneous CEA/CABG, a history of unrelated
CABG, closely staged contralateral CEA, carotid patching
and patch material (no patch, vein patch or synthetic
patch), the year of operation, and whether CEA was a
primary procedure or represented a reoperation for recur-
rent carotid stenosis after a primary procedure elsewhere.
Associations with postoperative outcomes were as-
sessed univariably and multivariably by using generalized
estimating equation models to adjust for the possible cor-
relation between bilateral CEAs in the same patient.10
Postoperative results are presented as odds ratios (OR) and
95% confidence intervals (CI) with corresponding P values.
Kaplan-Meier analysis was used to describe long-term sur-
vival, and associations between death and baseline factors
were assessed univariably and multivariably with Cox pro-
portional hazards regression models. For the purpose of
analysis, recurrent stenosis was defined as 60% stenosis
that was observed on any objective follow-up test. Univa-
riable and multivariable associations between recurrent ste-
nosis and baseline factors were assessed by using general-
ized estimating equation models that adjusted for the log-
transformed length of follow-up for each patient.
Multivariable models were developed by considering
factors that were significant univariably at P  .20, retain-
ing those with P  .05 within the model. A significance
level of .05 was used for all hypotheses, but Bonferroni
correction for multiple comparisons was used for factors
that had more than two levels. With Bonferroni correction,
the significance criterion was .05 divided by the number of
comparisons. Despite the size of this personal series, the
appropriate use of Bonferroni correction and the compar-
atively low number of synthetic patches placed certain
limitations on the ability to detect clinically important
differences. For instance, although there was 90% power at
the .05 significance level to detect a relative risk for ipsilat-
eral postoperative stroke of 0.31 between vein patching
(n  1232) and primary closure (n  783), there was only
23% power to detect a halving of the ipsilateral stroke rate
between vein patching and synthetic patching (n  247).
All data were analyzed with SAS software (SAS Institute
Inc., Cary, NC).
RESULTS
Postoperative death. Early death was attributed to
CEA if it occurred 30 days of the operation or if the
patient still was confined to the hospital with postoperative
complications for 30 days. An exception was made for
nine patients who recovered uneventfully from isolated
CEA but died with unrelated complications after other
vascular (n  7), pulmonary (n  1), or cardiac valve (n 
1) procedures that were performed 30 days. On univari-
able analysis, there was a significant association (P  .001)among the operative mortality rates for CEA alone (17/
1775, 1.0%), for CEA in conjunction with staged CABG
procedures (7/184, 3.8%) and for simultaneous CEA/
CABG (15/303, 5.0%). The seven deaths after staged
procedures included one (1.1%) of the 93 patients who had
CABG first, compared to six (6.6%) of the 91 patients who
had CEA first (P .11). Four of the six deaths in the latter
group were caused by myocardial infarctions (n  2) or
cardiac arrhythmias (n  2) before CABG could be per-
formed.
Simultaneous CEA/CABG (OR, 3.5; 95% CI, 1.7 to
7.5; P  .001) and increasing severity of contralateral
carotid stenosis (P  .001) were independently associated
with higher operative mortality rates on multivariable anal-
ysis (Table III). Advancing age was a marginal risk factor (P
 .051). Vein patching appeared to be associated with a
lower operative mortality rate (OR, 0.45; 95% CI, 0.20 to
1.0; P  .049) than primary closure, but only if the Bon-
ferroni correction for three comparisons (criterion for sig-
nificance, P .017) was not applied. Vein patching was not
significantly different from synthetic patching (P  .96).
Postoperative stroke. Although the absence of inde-
pendent verification by a consultant neurologist represents
a potential limitation of this study, postoperative stroke was
defined as any neurologic ormonocular visual deficit lasting
24 hours irrespective of its severity. All such deficits were
investigated either by prompt re-exploration or by some
form of objective carotid imaging to determine whether
ICA thrombosis had occurred.11,12 On univariable analysis,
there was a significant association (P  .015) among the
postoperative stroke rates for CEA alone (29/1775, 1.6%),
for CEA in conjunction with staged CABG procedures
(6/184, 3.3%), and for simultaneous CEA/CABG (16/
303, 5.3%). Eight of the 16 strokes that occurred after
simultaneous CEA/CABG involved cerebral territories
that were not directly supplied by the operated carotid
artery, compared with only one (2.9%) of the 35 strokes
after isolated CEA. There was no significant difference in
the incidence of ipsilateral postoperative stroke after iso-
lated CEA (34/1959, 1.7%) vs simultaneous CEA/CABG
(8/303, 2.6%; P  .41). Ipsilateral strokes occurred in 25
(1.7%) of the 1503 patients who presented with asymptom-
atic carotid stenosis, in nine (1.7%) of the 542 patients with
a history of previous retinal ischemia or cortical TIAs, and
in eight (3.7%) of the 217 patients with prior strokes.
Increasing severity of preoperative carotid symptoms was
not significantly associated with ipsilateral postoperative
stroke by univariable analysis (P  .13), but it was signifi-
cant (P  .046) in a multivariable model (Table III).
As illustrated in Fig 1, carotid patch categories were
associated with significant univariable differences in ipsilat-
eral stroke rates (P  .028). Vein patching had a lower
incidence of ipsilateral stroke (14/1232, 1.1%) than pri-
mary closure (22/783, 2.8%; P  .011) but was not
significantly different from synthetic patching (6/247,
2.4%; P  .08). The documented incidence of postopera-
tive carotid thrombosis was 1.5% (12/783) with primary
ods).
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247) with synthetic patching. These differences were not
significant (P  .088). Gender and the type of synthetic
patch (fabric vs PTFE) had no statistical interaction with
the relationship between carotid patching and the inci-
dence of either ipsilateral stroke or postoperative carotid
thrombosis.
On multivariable analysis (Table III), simultaneous
CEA/CABG procedures were associated with a higher risk
for any postoperative stroke (OR, 3.2; 95% CI, 1.6 to 6.4;
P  .001) but not for ipsilateral stroke (P  .16). The risk
for ipsilateral stroke was lower with vein patching (OR,
0.42; 95% CI 0.21 to 0.86; P  .015) than with primary
closure, but the difference between vein patching and
synthetic patching was not significant (P  .10).
Combined stroke and mortality. Univariable associ-
ations with CSM are presented in Appendix 1 (online only).
As shown in Fig 2, there was a significant association (P 
Table III. Multivariable associations with postoperative d
Postoperative death (C-statistic, .74)
Simultaneous CEA/CABG
Increasing severity of contralateral carotid stenosis
Advancing categorical age (per level)
Patch material
Primary closure (reference set)
Vein patch
Synthetic patch
Model also included increasing severity of ipsilateral carotid
stenosis (P  .086)
Any postoperative stroke (C-statistic, .64)
Simultaneous CEA/CABG
Patch material
Primary closure (reference set)
Vein patch
Synthetic patch
Model also included increasing severity of contralateral (P  .34)
and ipsilateral (P  .48) carotid stenosis
Ipsilateral postoperative stroke (C-statistic, .63)
Patch material
Primary closure (reference set)
Vein patch
Synthetic patch
Increasing severity of preoperative carotid symptoms
Model also included staged and simultaneous CABG (P  .16)
Combined stroke and/or death (C-statistic, .73)
Simultaneous CEA/CABG
Increasing severity of contralateral carotid stenosis
Closely staged contralateral CEA
Increasing severity of preoperative carotid symptoms
Patch material
Primary closure (reference set)
Vein patch
Synthetic patch
Model also included unrelated CABG (P  .11)
GEE, Generalized estimating equation;CEA, carotid endarterectomy;CABG
vein patching.
*Significant if P  .05 for overall test.
†Significant with Bonferroni correction for multiple comparisons (see Meth.001) among the CSMs for CEA alone (2.4%), for CEA inconjunction with staged CABG procedures (5.4%), and for
simultaneous CEA/CABG (8.9%). The CSM for staged
procedures was 6.6% (6/91) when CEA was done before
CABG vs 4.3% (4/93) when CABG preceded CEA, but
this difference was not significant (P  .53). Increasing
severity of contralateral carotid stenosis was associated with
higher CSMs when considered as an ordinal factor (P 
.025). Previous unrelated CABG (P  .001) and closely
staged contralateral CEA (P  .001) had low CSMs.
On multivariable analysis (Table III), simultaneous
CEA/CABG was associated with a high CSM (OR, 3.4;
95% CI, 2.0 to 5.8; P  .001). Increasing severity of
contralateral carotid stenosis (P  .001) or preoperative
carotid symptoms (P  .01) also had high CSMs, while
closely staged contralateral CEA had a low CSM (P .01).
The CSM was lower with vein patching (OR, 0.58; 95% CI
0.35 to 0.98; P  .042) than with primary closure using a
significance criterion of .05, but not after the Bonferroni
or stroke
Odds ratio (95%
CI) GEE P*
3.5 (1.7, 7.5) 0.001
1.6 (1.2, 2.1) 0.001
1.6 (1.0, 2.6) 0.051
0.12
1 .31 vs SP
0.45 (0.20, 1.0) .049 vs PC
0.46 (0.10, 2.1) .96 vs VP
3.2 (1.6, 6.4) 0.001
0.14
1 .74 vs SP
0.58 (0.31, 1.1) .078 vs PC
1.2 (0.45, 3.1) .082 vs VP
0.045
1 .97 vs SP
0.42 (0.21, 0.86) .015 vs PC†
1.1 (0.40, 2.9) .10 vs VP
1.3 (1.0, 1.8) 0.046
3.4 (2.0, 5.8) .001
1.4 (1.2, 1.7) .001
0.07 (0.01, 0.53) 0.01
1.3 (1.1, 1.7) 0.01
0.087
1 .84 vs SP
0.58 (0.35, 0.98) .042 vs PC
1.1 (0.44, 2.7) .16 vs VP
nary artery bypass grafting; SP, synthetic patching; PC, primary closure;VP,eath
, corocorrection for multiple comparisons was applied. Vein
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ing (P . 16).
Late survival. Long-term outcome was assessed by
using univariable and multivariable Cox proportional haz-
ards models for any postoperative or late death as well as by
Kaplan-Meier survival estimates extending to 15 years of
follow-up (Appendix 2, online only). Kaplan-Meier survival
was 92% at 1 year, 71% at 5 years, 41% at 10 years, and 20%
at 15 years for the entire series. On multivariable analysis
(Table IV), long-term mortality rates were higher after
simultaneous CEA/CABG (hazard ratio, 1.3; 95% CI, 1.1
to 1.5; P  .002) than after CEA alone. Advancing age (P
 .001) and increasing severity of contralateral carotid
stenosis (P  .001) also were associated with higher long-
term mortality rates, whereas women (P  .002) and
Fig 1. Postoperative ipsilateral stroke rates for all 2262 opera-
tions according to the method used for arteriotomy closure. The
number of patients at risk in each group is designated within each
bar.
Fig 2. Combined postoperative stroke and mortality rates for
carotid endarterectomy (CEA) only, for coronary artery bypass
grafting (CABG) in conjunction with staged CEA, and for simul-
taneous CEA/CABGprocedures. The number of patients at risk in
each group is designated within each bar.patients who had closely staged contralateral CEA (P .006) had low long-term mortality rates. Associations
among patchmaterials andmortality rates did not attain the
level of statistical significance required by the Bonferroni
correction.
Late stroke. The late neurologic status was unobtain-
able after 306 (14%) of the 2229 CEAs in operative survi-
vors. Unlike survival, which could be established with rea-
sonable accuracy using the Social Security Death Index, the
neurologic status in the remaining patients could be deter-
mined only to the date of the last documented follow-up at
a median (quartiles) interval of 4.7 (2.1, 8.5) postoperative
years (Table V). This incomplete dataset was not assessed
statistically because of the possibility for under-reporting,
but late strokes were known to have occurred after 97
(5.0%) of the 1923 eligible CEAs, 87 of which were man-
ifest by cortical symptoms (4.5%) and 10 by retinal infarc-
tions (0.5%). A total of 45 hemispheric strokes (n 39) or
retinal infarctions (n  6) were ipsilateral to CEA (2.3%),
and 40 cortical strokes (n  36) or retinal infarctions (n 
4) were on the contralateral side (2.1%). The remaining 12
strokes (0.6%) involved the posterior cerebral circulation,
two of which were considered to be hypertensive brainstem
infarctions. Late strokes or retinal infarctions are known to
have occurred after 60 (4.6%) of the 1294CEAs inmen and
after 37 (5.9%) of the 629 CEAs in women. The incidence
of these events was 4.2% (9/215) in patients with contralat-
eral ICA or CCA occlusions.
Recurrent carotid stenosis. Themaximum severity of
recurrent ICA stenosis was assessed after 1306 operations
for which the results of at least one objective follow-up test
were available. A total of 758 (89%) of the 852 men and
404 (89%) of the 454 women were found to have either no
new lesions or60% recurrent stenosis. Recurrent stenosis
of greater severity has occurred in 19% of men and 15% of
women after primary closure, in 8.3% of men and 8.6% of
women after vein patching, and in 6.9% of men and 14% of
women after synthetic patching. The median length of
follow-up (quartiles) was 11 (7.4, 16) years for patients
who developed 60% recurrent stenosis, compared to 5.3
(2.1, 8.9) years for those who did not.
Multivariable associations with 60% recurrent steno-
sis are presented in Table VI. Two statistical models were fit
to this analysis, the first model used two patch-related
variables (no patch vs any patch) and the second model
used three variables (no patch vs vein patch vs synthetic
patch). Patching of any kind was independently associated
with the incidence of 60% recurrent stenosis (OR, 0.61;
95% CI, 0.40 to 0.92; P  .019), but no significant
difference was demonstrated between patch materials (P
.11). Longer follow-up times (P  .001) and younger
patient age (P  .001) were associated with higher recur-
rence rates in both statistical models, and a history of
ipsilateral CEA also proved to be a significant risk factor (P
 .001) for recurrent stenosis in the first model.
Late ipsilateral reoperations have been performed after
10% (37/365) of all eligible CEAs that were done using
primary closure vs 5.4% (50/941) of those that used patch-
ing (vein, 5.8%; synthetic, 3.6%). The time to reoperation
ods).
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1.2; P  .34) was not significantly different.
DISCUSSION
The operative mortality (5.0%) and postoperative
stroke (5.3%) rates for simultaneous CEA/CABG in this
series were similar to the 5.5% and 4.8%, respectively, that
have been reported for a total of 805 CEA/CABG proce-
dures at The Cleveland Clinic since 198013-15 and compare
favorably with the CSM of 18% (stroke, 12%; death, 6.6%)
from a 10-state Medicare demonstration project in 1995
and 1996.16 The common observation that CEA/CABG
has a higher early risk than isolated CEA is probably related
to the widespread atherosclerosis that is often present in
patients who are selected for simultaneous procedures.17
Blauth et al18 discovered a significant association (P 
.001) between intraoperative atheroemboli and either pe-
ripheral vascular disease or severe atherosclerosis of the
ascending aorta in an autopsy study of patients who died
after CABG, the brain representing the most common
embolic target organ. This is consistent with the finding
that eight of the 16 postoperative strokes after simulta-
neous CEA/CABG in the present series involved cerebral
territories that were not directly supplied by the operated
carotid artery, whereas the ipsilateral stroke rate for CEA/
CABG was not significantly different from isolated CEA
(2.6% vs 1.7%, P  .41).
The risk of fatal cardiac complications during the inter-
Table IV. Multivariable associations with any postoperativ
Advancing categoric age
65 (reference set)
66 to 74
75
Severity of contralateral carotid stenosis
60% (reference set)
60% to 79%
80% to 99%
ICA or CCA occlusion
Female gender
Closely staged contralateral CEA
Staged or simultaneous CEA and CABG
CEA alone (reference set)
Staged CABG first
Staged CEA first
Simultaneous CEA/CABG
Patch material
Primary closure (reference set)
Vein patch
Synthetic patch
Model also included increasing severity of preoperative carotid sym
and era of operation (1991-2003 vs 1976-1990, P  .31)
ICA, Internal carotid artery;CCA, common carotid artery;CEA, carotid en
primary closure; VP, vein patching.
*Wald test from Cox proportional hazards regression.
†Significant if P  .05 for overall test.
‡Significant with Bonferroni correction for multiple comparisons (see Methval between conventionally staged CEA and CABG proce-dures (ie, CEA first) has been estimated at 12% to 20% in
small series of 20 patients.19,20 Four of the six deaths after
conventionally staged CEA in the present series were
caused by cardiac events, but neither the operative mortal-
ity rate nor the CSM was significantly associated with the
sequence of surgical staging. An intriguing relationship was
found between the CSM and the various settings for CEA
(Fig 2), which could have been influenced by patient selec-
tion in a retrospective study but does suggest that staged
procedures may be safer than simultaneous CEA/CABG.
The management of patients with coexistent carotid and
coronary disease must be tailored to the severity of their
symptoms and the extent of their arterial lesions, but pre-
vious randomized data from The Cleveland Clinic indicate
that CABG can be staged safely before CEA in patients who
have asymptomatic unilateral carotid stenosis.14 This
staged approach also may be appropriate for patients who
have medical comorbidities or require coronary artery re-
operations or cardiac valve repair that would add still fur-
ther to the complexity of simultaneous CEA/CABG.
Simultaneous CEA/CABG represented 13% of the op-
erations in this report and only 226 (2.1%) of the 10,561
CEAs in the 10-state Medicare demonstration project.16 A
widely applicable precaution like carotid patching might,
therefore, be expected to have a broader impact than simul-
taneous CEA/CABG on the overall outcome of CEA in
most practice settings. Eikelboom et al21 first reported a
lower incidence of 50% recurrent stenosis at 1 year of
late death.
Hazard ratio
(95% CI) P*†
.001
1
1.7 (1.5, 1.9) .001‡
2.8 (2.3, 3.3) .001‡
.001
1
1.2 (0.99, 1.4) 0.063
1.6 (1.2, 2.0) .001‡
1.3 (1.1, 1.6) .001‡
0.82 (0.73, 0.93) 0.002
0.70 (0.55, 0.89) 0.003
0.006
1
1.2 (0.95, 1.6) 0.11
0.91 (0.71, 1.2) 0.43
1.3 (1.1, 1.5) .002‡
0.051
1 .10 vs SP
0.89 (0.78, 1.0) .32 vs PC
1.1 (0.88, 1.5) .049 vs VP
s (P  .06)
ectomy;CABG, coronary artery bypass grafting; SP, synthetic patching; PC,e or
ptom
darterfollow-up for vein patching vs primary closure (3.5% vs
ynthe
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CEAs, a finding that was particularly evident in women.
Large nonrandomized series of isolated CEA at The Cleve-
land Clinic later revealed significantly lower risks for post-
operative stroke (0.7% vs 3.1%, P  .008), early ICA
thrombosis (0.5% vs 3.1%, P  .003) and 30% recurrent
stenosis at 3 years (9% vs 31%, P  .007) for vein patching
vs primary closure,22 as well as a significant reduction in the
late ipsilateral stroke rate (risk ratio [RR], 0.29; 95% CI,
0.12 to 0.71; P  .006) for vein patching vs synthetic
patching.23 Archie24 encountered higher risks for any late
stroke (RR, 1.3; 95% CI, 1.0 to 1.7; P  .04) and either
50% (5.7% vs 0.6%, P .001) or70% recurrent stenosis
(3.1% vs 0.3%, P  .001) at 3 years for fabric patching vs
vein patching in a personal series of 1360 primary CEAs,
and others also have described significantly higher rates of
50% recurrent stenosis for fabric patches than for vein
Table V. Reported late strokes or retinal infarctions.
Total
(n  1923)
n %
Ipsilateral to CEA 45 2.3 2
Retinal infarction 6 0.3
Cortical stroke 39 2 1
Contralateral to CEA 40 2.1 1
Retinal infarction 4 0.2
Cortical stroke 36 1.9 1
Other vascular territories 12 0.6
Cortical stroke 10 0.5
Brainstem infarction 2 0.1
Total* 97 5 4
CEA, Carotid endarterectomy.
*The late neurologic status was unobtainable after 306 (14%) of 2229 eligib
patches.
Table VI. Multivariable associations with 60% or greater r
Ca
Model 1 (2-level patch variable)
Log-transformed length of follow-up (y)
Advancing categoric age (y) 65 (referenc
66 to 74
75
Previous ipsilateral CEA
Any patch
Model also included female gender
(P.12)
Model 2 (3-level patch variable)
Log-transformed length of follow-up (y)
Advancing categoric age (y) 65 (referenc
66 to 74
75
Patch material Primary closur
Vein patch
Synthetic patc
Model also included female gender (P  .12)
GEE, Generalized estimating equation; CEA, carotid endarterectomy; SP, spatches within 3 years of follow-up.25-27Patching of any kind was associated with a significant
reduction (P  .001) in the incidence of 60% recurrent
stenosis in the surgical cohort of the Asymptomatic Carotid
Atherosclerosis Study trial,28 but smaller randomized con-
trolled trials that were specifically designed to address the
choice between vein patches and synthetic patches have
produced conflicting results. For example, a trial of vein
patching vs fabric patching (Hemashield and Hemashield
Finesse, Boston Scientific, Natick, Mass) at The Cleveland
Clinic failed to show any significant differences in restenosis
rates at a median follow-up interval of 15 months in 195
patients,29 whereas Naylor et al30 found in a similar trial
that vein patches were associated with a lower incidence of
70% recurrent stenosis than Hemashield Finesse patches
(1.6% vs 7.1%, P  .03) at 3 years of follow-up in 273
patients. Bond et al31 summarized the current evidence
base for carotid patching in a recent review of 13 random-
ary closure
 644)
Vein patch
(n 1061)
Synthetic patch
(n  218)
% n % n %
3.1 20 1.9 5 2.3
0.3 2 0.2 2 0.9
2.8 18 1.7 3 1.4
3 17 1.6 4 1.8
0.2 3 0.3 0 —
2.8 14 1.3 4 1.8
0.6 6 0.6 2 0.9
0.5 5 0.5 2 0.9
0.2 1 0.1 0 —
6.7 43 4.1 11 5
rations, including 123 primary closures, 156 vein patches, and 27 synthetic
rent stenosis.
Odds Ratio
(95% CI)
GEE P vs.
reference Overall
2.9 (1.9, 4.4) .001
1 .001
0.36 (0.22, 0.58) .001
0.30 (0.13, 0.69) 0.005
6.2 (2.9, 13) .001
0.61 (0.40, 0.92) 0.019
2.7 (1.8, 4.2) .001
1 .001
0.35 (0.22, 0.57) .001
0.26 (0.11, 0.60) 0.002
erence set) 1 .98 vs SP 0.11
0.66 (0.43, 1.0) .055 vs PC
1.0 (0.51, 2.0) .20 vs VP
tic patching; PC, primary closure; VP, vein patching.Prim
(n
n
0
2
8
9
1
8
4
3
1
3
le opeecur
tegory
e set)
e set)
e (ref
hized trials and concluded that although patching generally
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early or late stroke, postoperative carotid thrombosis, and
recurrent stenosis, more data are necessary to establish
differences between various patch materials.
In the present series, patching was univariably associated
(P .028) with a lower incidence of ipsilateral postoperative
stroke compared with primary arteriotomy closure. On mul-
tivariable analysis, early event ratios (vs primary closure) for
vein patching were consistently if not significantly lower than
for synthetic patchingwith respect to ipsilateral stroke (0.42 vs
1.1, P  .10), any postoperative stroke (0.58 vs 1.2,
P  .082), and CSM (0.58 vs 1.1, P  .16) even though
synthetic patching was not used during simultaneous CEA/
CABG and thus was not exposed to the higher postoperative
stroke and mortality rates in this group of patients. Further-
more, assuming the same 5:1 ratio of vein patches to synthetic
patches as in the present series, approximately 11,000 CEAs
would have been necessary to provide sufficient statistical
power to detect a halving of the ipsilateral stroke rate between
these two patch materials. Patching of any kind was indepen-
dently associated with a lower incidence of 60% recurrent
stenosis than primary closure in this series (OR, 0.61; 95%CI,
0.40 to 0.92; P  .019), but there again was no significant
difference between patch materials on multivariable analysis.
However, based largely on the data displayed in Fig 1 for
ipsilateral postoperative stroke, the senior author retains a
personal preference for vein patching.
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Appendix 1, online only. Univariable associations with any postoperative stroke and/or death.
Odds Ratio
(95% CI)
GEE
P-value*%
.5 NA NA
.4 1.0 .81
.6 1.1
(0.66, 1.7)
.1 1.0 .56
.0 1.3
(0.80, 2.2)
.3 1.1
(0.55, 2.0)
1.07 .63
(0.81, 1.4)
.3 1.0 .18
.2 0.68
(0.29, 1.6)
.1 1.2
(0.63, 2.4)
.0 1.9
(1.0, 3.5)
1.2 .14
(0.97, 1.5)
.5 1.0 .48
.5 0.70
(0.24, 2.1)
.7 1.05
(0.44, 2.5)
1.1 .53
(0.74, 1.7)
.7 1.0 .11
.7 0.97
(0.41, 2.3)
.4 2.3
(1.2, 4.5)
.2 1.9
(1.03, 3.6)
1.3 .025
(1.1, 1.6)
.5 1.0 .56
.6 0.70
(0.17, 2.8)
.4 1.0 .001
.4 2.3
(1.2, 4.7)
.9 4.0
(2.4, 6.6)
2.0 .001
(1.6, 2.6)
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968.e1Category n
Combined Stroke
and/or Death
n
All operations NA 2262 79 3
Gender Men 1521 52 3
Women 741 27 3
Age (y) 66 965 30 3
66-74 897 36 4
74 400 13 3
Per level
Preoperative ipsilateral symptoms None 1503 49 3
Retinal 271 6 2
TIA 271 11 4
Stroke 217 13 6
Per level
Preoperative ipsilateral stenosis 60% 170 6 3
60% to 79% 325 8 2
80% to 99% 1767 65 3
Per level
Preoperative contralateral
stenosis (data not available for
75 operations)
60% 1504 41 2
60% to 79% 224 6 2
80% to 99% 188 12 6
Occlusion 271 14 5
Per level
Reoperative CEA No 2184 77 3
Yes 78 2 2
Composite analysis of CEA
alone, staged CEA and CABG
procedures, and simultaneous
CEA/CABG
CEA alone 1775 42 2
Staged CEA and CABG procedures 184 10 5
Simultaneous CEA/CABG 303 27 8
Per level
Appendix 1, online only. Continued
Category n
Combined Stroke
and/or Death
Odds Ratio
(95% CI)
GEE
P-value*n %
Composite analysis including the
sequence of staged CEA and
CABG procedures
CEA alone 1775 42 2.4 1.0 .001
Staged CABG first 93 4 4.3 1.9
(0.66, 5.2)
Staged CEA first 91 6 6.6 2.8
(1.2, 6.7)
Simultaneous CEA/CABG 303 27 8.9 4.0
(2.4, 6.6)
Per level 1.6 .001
(1.3, 1.9)
Previous unrelated CABG No 1803 73 4.1 1.0 .001
Yes 459 6 1.3 0.32
(0.14, 0.73)
Closely staged contralateral CEA No 2040 78 3.8 1.0 .001
Yes 222 1 0.5 0.11
(0.01, 0.85)
Carotid patch No 783 36 4.6 1.0 .054
Yes 1479 43 2.9 0.62
(0.40, 0.98)
Patch material No patch 783 36 4.6 1.0 .16
Vein patch 1232 36 2.9 0.63
(0.39, 1.0)
Synthetic patch 247 7 2.8 0.62
(0.28, 1.4)
Synthetic patches Fabric 188 4 2.1 1.0 .33
PTFE 59 3 5.1 2.5
(0.53, 11.4)
Year of operation 1976-1980 489 23 4.7 1.0 .24
1981-1985 583 18 3.1 0.65
(0.35, 1.2)
1986-1990 417 12 2.9 0.61
(0.30, 1.2)
1991-1995 341 16 4.7 1.0
(0.51, 2.0)
1996-2002 432 10 2.3 0.48
(0.23, 1.0)
Per level 0.90 .22
(0.77, 1.1)
Era of operation 1976-1985 1072 41 3.8 1.0 .43
1986-2002 1190 38 3.2 0.83
(0.53, 1.3)
GEE, Generalized estimating equation; NA, not applicable; TIA, transient ischemic attack; CEA, carotid endarterectomy; CABG, coronary artery bypass grafting; PTFE, polytetrafluoroethelene
*significant if P  .05
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Appendix 2, online only. Univariable associations with any postoperative or late death.
Category n
Kaplan-Meier Survival Estimate (95% CI)
Hazard Ratio
(95% CI)
P-value
1 Year (%) 5 Years (%) 10 Years (%) 15 Years (%)
Versus
Reference Overalla
All patients* NA 1927 92 (91, 94) 71 (69, 73) 41 (39, 44) 20 (18, 22) NA NA NA
Gender Men 1294 91 (90, 93) 69 (66, 72) 40 (37, 43) 19 (16, 22) 1.0 .11
Women 633 94 (92, 96) 75 (71, 78) 43 (29, 48) 21 (17, 26) 0.91
(0.81, 1.0)
Age (y) 66 832 95 (94, 97) 79 (76, 82) 54 (50, 58) 31 (27, 35) 1.0 .001
66-74 752 91 (88, 93) 67 (64, 71) 36 (32, 40) 13 (10, 16) 1.7 .001b
(1.5, 2.0)
74 343 89 (86, 93) 59 (53, 65) 19 (13, 24) 1.7 (0, 3.9) 2.6 .001b
(2.2, 3.1)
Per level 1.6 .001
(1.5, 1.8)
10-y 1.6 .001
increments (1.5, 1.8)
Preoperative ipsilateral
symptoms
None 1245 93 (91, 94) 72 (69, 74) 40 (37, 44) 18 (15, 21) 1.0 .011
Retinal 234 93 (90, 97) 73 (67, 79) 51 (44, 58) 28 (21, 35) 0.79 .008b
(0.67, 0.94)
TIA 252 93 (89, 96) 68 (62, 74) 42 (35, 49) 22 (16, 29) 0.99 .94
(0.84, 1.2)
Stroke 196 88 (83, 92) 66 (59, 73) 34 (27, 42) 18 (11, 24) 1.1 .14
(0.96, 1.4)
Per level 1.0 .45
(0.97, 1.1)
Preoperative ipsilateral
stenosis
60% 142 93 (88, 97) 70 (62, 77) 42 (34, 51) 27 (19, 35) 1.0 .71
60% to 79% 268 94 (91, 97) 71 (65, 77) 40 (34, 47) 20 (14, 26) 1.1 .46
(0.86, 1.4)
80% to 99% 1517 92 (91, 93) 71 (69, 73) 41 (39, 44) 19 (16, 21) 1.1 .43
(0.89, 1.3)
Per level 1.0 .53
(0.94, 1.1)
Preoperative
contralateral stenosis
(data not available
for 72 patients)
60% 1178 93 (92, 95) 73 (70, 76) 43 (40, 47) 21 (18, 24) 1.0 .001
60% to 79% 224 93 (90, 96) 70 (63, 76) 33 (25, 41) 14 (7.9, 20) 1.2 .053
(1.0, 1.4)
80% to 99% 185 90 (86, 95) 66 (58, 73) 37 (29, 45) 19 (12, 26) 1.2 .028
(1.0, 1.5)
Occlusion 268 89 (85, 93) 63 (57, 69) 33 (26, 39) 13 (7.8, 18) 1.4 .001b
(1.2, 1.6)
Per level 1.1 .001
(1.1, 1.2)
Reoperative CEA No 1858 92 (91, 93) 71 (69, 73) 42 (39, 44) 20 (18, 22) 1.0 .16
Yes 69 95 (90, 100) 71 (60, 82) 37 (24, 51) 11 (0.9, 22) 1.2
(0.93, 1.6)
Simultaneous CEA/
CABG
No 1639 93 (92, 94) 71 (68, 73) 43 (40, 46) 21 (19, 24) 1.0 .014
Yes 288 89 (85, 93) 71 (66, 77) 34 (28, 40) 19 (8.5, 18) 1.2
(1.0, 1.4)
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Appendix 2, online only. Continued
Hazard Ratio
(95% CI)
P-value
Versus
Reference Overalla
1.0 .019
1.3 .062
(0.99, 1.6)
0.91 .45
(0.72, 1.2)
1.2 .01
(1.1, 1.4)
1.0 .032
(1.0, 1.1)
1.0 .82
0.98
(0.84, 1.1)
1.0 .41
0.93
(0.79, 1.1)
1.0 .41
1.0 .18
(0.91, 1.2)
1.2 .73
(0.93, 1.5)
1.0 .12
1.1 .15
(0.96, 1.3)
1.2 .049
(1.0, 1.4)
1.2 .037
(1.0, 1.5)
1.3 .058
(0.99, 1.6)
1.1 .010
(1.0, 1.1)
1.0 .030
1.1
(1.0, 1.3)
rafting
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Kaplan-Meier Survival Estimate (95% CI)
1 Year (%) 5 Years (%) 10 Years (%) 15 Years (%)
Composite analysis of
CEA alone, staged
CEA and CABG
procedures, and
simultaneous CEA/
CABG
CEA alone 1467 93 (92, 94) 71 (68, 73) 43 (40, 46) 22 (19, 24)
Staged
CABG first
85 95 (91, 100) 71 (61, 81) 36 (25, 47) 6.0 (0, 12)
Staged CEA
first
87 88 (81, 95) 69 (58, 79) 49 (38, 59) 28 (18, 38)
Simultaneous
CEA/CABG
288 89 (85, 93) 71 (66, 77) 34 (28, 40) 19 (8.5, 18)
Per level
Previous unrelated
CABG
No 1579 92 (91, 93) 71 (69, 74) 42 (39, 44) 20 (18, 22)
Yes 348 94 (91, 96) 69 (64, 75) 40 (34, 47) 19 (13, 25)
Closely staged
contralateral CEA
No 1705 92 (91, 93) 71 (68, 73) 41 (38, 43) 19 (17, 22)
Yes 222 95 (92, 98) 72 (66, 78) 47 (40, 54) 23 (17, 30)
Patch material No patch 659 90 (88, 93) 68 (64, 71) 40 (36, 44) 21 (18, 25)
Vein patch 1073 93 (92, 95) 73 (70, 76) 43 (39, 46) 18 (15, 22)
Synthetic 195 94 (91, 97) 69 (62, 76) 38 (27, 48) 13 (1.0, 25)
patch
Year of operation 1976-1980 423 91 (89, 94) 70 (65, 74) 45 (40, 50) 24 (19, 28)
1981-1985 480 90 (88, 93) 69 (65, 73) 39 (35, 44) 21 (18, 25)
1986-1990 346 93 (90, 96) 72 (67, 77) 45 (39, 50) 15 (10, 19)
1991-1995 293 94 (91, 97) 75 (69, 80) 36 (29, 42) NA
1996-2002 385 94 (92, 97) 69 (63, 76) NA NA
Per level
Era of operation 1976-1985 903 91 (89, 93) 69 (66, 73) 42 (39, 45) 22 (20, 25)
1986-2002 1024 94 (92, 95) 72 (69, 75) 40 (36, 44) 13 (8.9, 17)
GEE, Generalized estimating equation; NA, not applicable; TIA, transient ischemic attack; CEA, carotid endarterectomy; CABG, coronary artery bypass g
*Survival data are based on the clinical profile preceeding the first operation in 335 patients who underwent bilateral CEA during the study period.
asignificant if P  .05 for overall test
bsignificant with Bonferroni correction for multiple comparisons (see Methods)
